Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h + HER2- breast cancer: a retrospective analysis. Kook Y, Lee YJ, Chu C, Jang JS, et al. Breast Cancer Res 2024;26:154.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kook Y, Lee YJ, Chu C, Jang JS, et al. Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h + HER2- breast cancer: a retrospective analysis. Breast Cancer Res 2024;26:154.
PMID: 39506855